ArticleWorld journal of hepatology2016

Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial.

Zaigham Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.